SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats - Yokono, M; Takasu, T; Hayashizaki, Y (Eur J Pharmacol, 2014)
et al.